Ablative Solutions
Andrew Tochterman is the Vice President and General Manager of the Coronary Segment at Philips (NYSE: PNG). In this role, he is responsible for the short-term management through long-term profitable growth strategy for the coronary business of ImageGuided Therapy (IGT) Devices.
Andrew has had roles in quality engineering, product development, clinical research, marketing & sales during his 18-year career in Cardiovascular Medical Devices. He has a Bachelors of Science in Chemical Engineering from Rose-Hulman Institute of Technology in Terre Haute, IN, and a Masters of Business Administration from the Wharton School of Business, University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Ablative Solutions
Ablative Solutions is a clinical-stage medical device start-up that is pioneering the novel approach of Transcatheter Perivascular Alcohol Denervation for the treatment of hypertension.